Villeneuve A, Arsenault V, Lacroix J, Tucci M. Neonatal red blood cell transfusion. Vox Sang. 2021;116:366–78.
Bell EF. Red cell transfusion thresholds for preterm infants: finally some answers. Arch Dis Child Fetal Neonatal Ed. 2022;107:126–30.
Colobatti R, Sainati L, Trevisanuto D. Anemia and transfusion in the neonate. Semin Fetal Neonatal Med. 2016;21:2–9.
Christensen RD, Baer VL, Lambert DK, Ilstrup SJ, Eggert LD, Henry E. Association, among very-low birthweight neonates, between red blood cell transfusions in the week after birth and severe intraventricular hemorrhage. Transfusion. 2014;54:104–8.
Ohlsson A, Aher SM. Early erythropoiesis-stimulating agents in preterm or low birth weight infants. Cochrane Database Syst Rev. 2017;11:CD004863.
Ohlsson A, Aher SM. Late erythropoiesis-stimulating agents to prevent red blood cell transfusion in preterm or low birth weight infants. Cochrane Database Syst Rev. 2020;1:CD004868.
Maier RF, Obladen M, Müller-Hansen I, Kattner E, Merz U, Arlettaz R, et al. Early treatment with erythropoietin β ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000g. J Pediatr. 2002;141:8–15.
Article CAS PubMed Google Scholar
El-Lahony DM, Saleh NY, Habib MS, Shehata MA, El-Hawy MA. The role of recombinant human erythropoietin in neonatal anemia. Hematol Oncol Stem Cell Ther. 2020;13:147–51.
Ohls RK, Osborne KA, Christensen RD. Efficacy and cost analysis of treating very low birth weight infants with erythropoietin during their first two weeks of life: a randomized, placebo-controlled trial. J Pediatr. 1995;126:421–6.
Article CAS PubMed Google Scholar
Ohls RK, Harcum J, Schibler KR, Christensen RD. The effect of erythropoietin on the transfusion requirements of preterm infants weighing 750 grams or less: a randomized, double blind, placebo-controlled study. J Pediatr. 1997;131:661–5.
Article CAS PubMed Google Scholar
Ohls RK, Ehrenkranz RA, Wright LL, Lemons JA, Korones SB, Stoll BJ, et al. Effects of early erythropoietin therapy on the transfusion requirements of preterm infants below 1250 grams birth weight: a multicenter, randomized, controlled trial. Pediatrics. 2001;108:934–42.
Article CAS PubMed Google Scholar
Juul SE, Vu PT, Comstock BA, Wadhawan R, Mayock DE, Courtney SE, et al. Effect of high-dose erythropoietin on blood transfusions in extremely low gestational age neonates: post hoc analysis of a randomized clinical trial. JAMA Pediatr. 2020;174:933–43.
Salsbury DC. Anemia of prematurity. Neonatal Netw. 2001;20:13–20.
Article CAS PubMed Google Scholar
Strauss RG. Anemia of prematurity: pathophysiology & treatment. Blood Rev. 2010;24:221–5.
Article CAS PubMed PubMed Central Google Scholar
Romagnoli C, Zecca E, Gallini F, Zuppa PGAA. Do recombinant human erythropoietin and iron supplementation increase the risk of retinopathy of prematurity? Eur J Pediatr. 2000;159:627–34.
Article CAS PubMed Google Scholar
Fischer HS, Reibel NJ, Bührer C, Dame C. Effect of early erythropoietin on retinopathy of prematurity: a stratified meta-analysis. Neonatology. 2023;120:566–76.
留言 (0)